Wide Ranks

DRUG

Bright Minds Biosciences Inc.

39.18

Top Statistics
Market Cap 268 M Forward PE 0.0000 Revenue Growth 0.00 %
Current Ratio 35.08 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 6 M Total Cash Per Share 1.39 Total Debt 14016
Total Debt To Equity 0.2300 Current Ratio 35.08 Book Value Per Share 1.37
All Measures
Short Ratio 4.00 % Message Board Id finmb_691048918 Shares Short Prior Month 1 M
Return On Equity -0.5180 City New York Uuid 7de90f41-6566-3a5c-a990-c3e8fec46e3b
Previous Close 38.11 First Trade Date Epoch Utc 1 B Book Value 1.37
Beta 1.13 Total Debt 14016 Volume 183889
Price To Book 28.68 Last Split Date 1 B Fifty Two Week Low 0.9300
Total Cash Per Share 1.39 Shares Short Previous Month Date 1 B Max Age 86400
Sand P52 Week Change 0.3133 Net Income To Common -3580629 Short Percent Of Float 0.0435
Implied Shares Outstanding 6 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 203880 Average Volume10days 203880 Total Cash 6 M
Next Fiscal Year End 1 B Held Percent Insiders 0.2728 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 38.11
Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000 Fifty Day Average 27.76
Open 39.00 Free Cashflow -1337075 State NY
Dividend Yield 0.00 % Return On Assets -0.2886 Time Zone Short Name EST
Trailing Eps -0.6300 Day Low 37.75 Address1 19 Vestry Street
Shares Outstanding 6 M Price Hint 2 Target High Price 0.0000
Website https://brightmindsbio.com 52 Week Change 28.24 Average Volume 2 M
Recommendation Key none Forward Eps 0.0000 Compensation As Of Epoch Date 1 B
Quick Ratio 3475.10 % Last Split Factor 1:5 Regular Market Day High 40.69
Is_sp_500 False Profit Margins 0.00 % Debt To Equity 0.2300
Fifty Two Week High 79.02 Day High 40.69 Shares Short 264763
Regular Market Open 39.00 Industry Key biotechnology Earnings Growth 0.00 %
Revenue Growth 0.00 % Shares Percent Shares Out 0.0380 Operating Cashflow -2584540
Currency USD Time Zone Full Name America/New_York Market Cap 268 M
Is_nasdaq_100 False Zip 10013 Quote Type EQUITY
Industry Biotechnology Long Name Bright Minds Biosciences Inc. Regular Market Day Low 37.75
Held Percent Institutions 0.4428 Current Price 39.18 Financial Currency CAD
Current Ratio 35.08 Industry Disp Biotechnology Country United States
Float Shares 631097 Two Hundred Day Average 7.85 Enterprise Value 168 M
Forward PE 0.0000 Regular Market Volume 183889 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder.

The company also developing BMB-202 for the treatment of depression, anxiety, and PTSD; and BMB-201 for the treatment of anxiety.

It has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin.

Bright Minds Biosciences Inc. was founded in 2017 and is headquartered in New York, New York.